The present invention is directed to 3,4-substituted pyrrolidine compounds of formula (I) which are inhibitors of the beta-secretase enzyme and that are useful in the treatment of diseases in which the beta-secretase enzyme is involved, such as Alzheimer's disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the treatment of such diseases in which the beta-secretase enzyme is involved.
本发明涉及式(I)的3,4-取代
吡咯烷化合物,其为β-分泌酶酶
抑制剂,可用于治疗涉及β-分泌酶酶的疾病,如阿尔茨海默病。该发明还涉及包含这些化合物的药物组合物,以及这些化合物和组合物在治疗涉及β-分泌酶酶的疾病中的用途。